Tazeen Ahmad Downgraded (BCRX) to Sell and Increased Target to $3 on, Jul 31st, 2013
Tazeen Ahmad of B of A Securities, Downgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Sell and Increased Target from $2 to $3 on, Jul 31st, 2013.
Tazeen, nor any peers, have made any analyst calls on BCRX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30